Rationale for the design of an oncology trial using a generic targeted therapy multidrug regimen for NSCLC patients without treatment options (Review)

Author：  

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.30, Iss.4, 2013-01, pp. : 1535-1541

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of Childhood Asthma: Options and Rationale for Inhaled Therapy

By Powell C.V.E.   Everard M.L.  

Drugs, Vol. 55, Iss. 2, 1998-02 ,pp. : 237-252

Adis International

Access to resources Recommend Favorite

An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial

By Kyriakides T.C.   Babiker A.   Singer J.   Cameron W.   Schechter M.T.   Holodniy M.   Brown S.T.   Youle M.   Gazzard B.   on behalf of the OPTIMA Study Team see Appendix  

Controlled Clinical Trials, Vol. 24, Iss. 4, 2003-08 ,pp. : 481-500

Elsevier

Access to resources Recommend Favorite

Early oncology clinical trial design in the era of molecular-targeted agents

By Brunetto Andre T   Kristeleit Rebecca S   de Bono Johann S  

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1339-1352

Future Medicine

Access to resources Recommend Favorite

Targeted therapy for NSCLC with driver mutations

By Minuti Gabriele   D'Incecco Armida   Cappuzzo Federico  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 10, 2013-10 ,pp. : 1401-1412

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy for the Pharmacological Management of Benign Prostatic Hyperplasia: Rationale and Treatment Options

By Sandhu Jaspreet S.  

Drugs & Aging, Vol. 22, Iss. 11, 2005-01 ,pp. : 901-912

Adis International

Access to resources Recommend Favorite